Peptide YY (1–36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β‐cell function, growth and survival

A Long-Acting PYY3–36 Analog Mediates Robust Anorectic Efficacy with Minimal Emesis in Nonhuman Primates

(2019) Shamina M. Rangwala et al.   Cell Metabolism

Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: Evidence for involvement of the GLP-1 receptor

(2018) Galyna V. Graham et al.   PEPTIDES

Emerging therapeutic potential for peptide YY for obesity-diabetes

(2018) Ryan A. Lafferty et al.   PEPTIDES

Y1 receptor deficiency in β-cells leads to increased adiposity and impaired glucose metabolism

(2018) Kim Loh et al.   Scientific Reports

Glucagon-like peptides-1 from phylogenetically ancient fish show potent anti-diabetic activities by acting as dual GLP1R and GCGR agonists

(2018) Galyna V. Graham et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes

(2017) Claudia Guida et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice

(2016) F. P. M. O'Harte et al.   DIABETES OBESITY & METABOLISM

Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival

(2016) Dawood Khan et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Novel dual agonist peptide analogues derived from dogfish glucagon show promising in vitro insulin releasing actions and antihyperglycaemic activity in mice

(2016) F.P.M. O'Harte et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 Diabetes following Roux-En-Y Gastric Bypass Surgery

(2016) Reshma D. Ramracheya et al.   Cell Reports

Sustained treatment with a stable long-acting oxyntomodulin analogue improves metabolic control and islet morphology in an experimental model of type 1 diabetes

(2015) N. Irwin et al.   DIABETES OBESITY & METABOLISM

Sequential induction of beta cell rest and stimulation using stable GIP inhibitor and GLP-1 mimetic peptides improves metabolic control in C57BL/KsJ db/db mice

(2015) Varun Pathak et al.   DIABETOLOGIA

β Cell death and dysfunction during type 1 diabetes development in at-risk individuals

(2015) Kevan C. Herold et al.   JOURNAL OF CLINICAL INVESTIGATION

Effects of PYY3–36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men

(2014) Julie Berg Schmidt et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Peptide YY: more than just an appetite regulator

(2014) Shanta J. Persaud et al.   DIABETOLOGIA

Gut motility and enteroendocrine secretion

(2013) Tongzhi Wu et al.   CURRENT OPINION IN PHARMACOLOGY

Selective Ablation of Peptide YY Cells in Adult Mice Reveals Their Role in Beta Cell Survival

(2012) Amir H. Sam et al.   GASTROENTEROLOGY

Analogs of pancreatic polypeptide and peptide YY with a locked PP-fold structure are biologically active

(2012) Natacha Germain et al.   PEPTIDES

Development and Functional Characterization of Insulin-releasing Human Pancreatic Beta Cell Lines Produced by Electrofusion

(2011) Jane T. McCluskey et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development

(2011) Cornelia Walther et al.   JOURNAL OF PEPTIDE SCIENCE

Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism?

(2008) Martin C. Michel et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY